In a paper in Nature Medicine co-authored by researchers from delivery company Nanotherapeutics and the National Cancer Institute (NCI), oral pH-dependent microparticles delivered a nanoparticle vaccine to the large intestine and triggered immunity in mice, protecting them against rectal and vaginal viral challenge. A vaccine using this technology could be given orally and could potentially protect people against HIV and other infections. Press release | Abstract
Like what you're reading?
Click here to get more news delivered to your inbox every week>>